sglt2 inhibitors vs glp 1 Benefits of treatment with SGLT2i and GLP-1RA based on their direct and SGLT2 Inhibitors vs. GLP-1 Agonists

In this study, the central mechanism underlying TAM lipid metabolic reprogramming relies on NP-mediated targeted siCB-2 delivery to TAMs, which silences CB-2 expression, disrupts the 2-AG signaling cascade, and redirects TAM polarization toward the pro-inflammatory M1 phenotype, ultimately restoring anti-tumor immune responses

is a family physician currently based in the Department of Endocrinology, Tan Tock Seng Hospital (TTSH), where she is part of the TTSH Weight Management Service

It is especially helpful for vegans, vegetarians, and people with absorption issues

For additional guidance or study-specific support, you can contact us anytime with further research-related questions